A Harvard professor is the latest member of a panel of FDA advisers to resign in protest over the agency’s decision to approve Biogen’s Alzheimer’s treatment
Third FDA panel member quits over Alzheimer’s drug approval
© The Crystal Eyes
A Harvard professor is the latest member of a panel of FDA advisers to resign in protest over the agency’s decision to approve Biogen’s Alzheimer’s treatment
© The Crystal Eyes